Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Mobilization
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-18